Literature DB >> 28515914

Analysis of the function of microRNA-375 in humans using bioinformatics.

Xiaohua Chen1, Baoxia Li2, Rongcheng Luo3, Sina Cai4, Cao Zhang1, Xiaolong Cao1.   

Abstract

MicroRNA-375 (miR-375) is expressed at low levels in many types of solid tumor, particularly in gastrointestinal tumors. It is considered to be important in the development of cancer and certain diseases. Thus, more detailed knowledge is required on the particular functions of miR-375. miRs function by regulating target genes. Therefore, in the current study, miRWalk (which includes the data from 10 prediction software programs) was used to predict the target genes of miR-375. The genes, which were co-predicted using five different software programs were further analyzed using Database for Annotation, Visualization and Integrated Discovery online software [including gene ontology (GO) and Kyoto Encyclopedia of Genes and Genomes (KEGG) pathway analysis]. Subsequently, the online tool, Search Tool for the Retrieval of Interacting Genes, was used to analyze the protein-protein interaction and construct modules using Cytoscape. The result demonstrated 6,574 predicted genes, 1,325 of which were co-predicted. The GO analysis result indicated that, in biological processes, the co-predicted genes were significantly enriched in the regulation of nervous system development and cell differentiation, and the highest enrichment of molecular function was ion binding. In KEGG analysis, the genes were enriched in the Hippo signaling pathway, glutamatergic synapse, circadian entrainment and the phosphoinositide 3-kinase (PI3K)-Akt signaling pathway. The top 10 hub proteins were mechanistic target of rapamycin, PH domain and leucine rich repeat protein phosphatase 1, ubiquitously transcribed tetratricopeptide repeat containing, Y-linked, histone deacetylase 2, F-box and leucine rich repeat protein 19, KIT proto-oncogene receptor tyrosine kinase, angiotensinogen, Janus kinase 2, fibroblast growth factor 2 and RNA polymerase II subunit A. These proteins predominantly regulate the development and progression of cancer, hypertension, essential thrombocythemia and inflammation. The genes in the top seven modules selected were identified to be primarily enriched in chemokines, extracellular matrix-receptor interaction, focal adhesion, the PI3K-Akt signaling pathway, amoebiasis and protein processing signaling pathway. Thus, the target genes and hub proteins that were predicted in the current study were identified to be important in regulating the development and progression of cancer and certain diseases. Furthermore, they present potential novel biomarkers for tumor diagnosis and candidate targets for treatment, and indicate that further research is required to establish the functions of miR-375.

Entities:  

Keywords:  biological information; disease; miR-375; regulation; target gene

Year:  2017        PMID: 28515914      PMCID: PMC5431329          DOI: 10.3892/br.2017.889

Source DB:  PubMed          Journal:  Biomed Rep        ISSN: 2049-9434


  37 in total

1.  MicroRNA-375 is downregulated in gastric carcinomas and regulates cell survival by targeting PDK1 and 14-3-3zeta.

Authors:  Yoshiyuki Tsukamoto; Chisato Nakada; Tsuyoshi Noguchi; Masato Tanigawa; Lam Tung Nguyen; Tomohisa Uchida; Naoki Hijiya; Keiko Matsuura; Toshio Fujioka; Masao Seto; Masatsugu Moriyama
Journal:  Cancer Res       Date:  2010-03-09       Impact factor: 12.701

2.  Cardiac angiotensin-(1-12) expression and systemic hypertension in rats expressing the human angiotensinogen gene.

Authors:  Carlos M Ferrario; Jessica VonCannon; Yan Jiao; Sarfaraz Ahmad; Michael Bader; Louis J Dell'Italia; Leanne Groban; Jasmina Varagic
Journal:  Am J Physiol Heart Circ Physiol       Date:  2016-02-12       Impact factor: 4.733

3.  Exosome-Carried microRNA-375 Inhibits Cell Progression and Dissemination via Bcl-2 Blocking in Colon Cancer.

Authors:  Florin Zaharie; Mihai Stefan Muresan; Bobe Petrushev; Cristian Berce; Grigore-Aristide Gafencu; Sonia Selicean; Ancuta Jurj; Roxana Cojocneanu-Petric; Cosmin-Ioan Lisencu; Laura-Ancuta Pop; Valentina Pileczki; Dan Eniu; Mihai-Andrei Muresan; Roxana Zaharie; Ioana Berindan-Neagoe; Ciprian Tomuleasa; Alexandru Irimie
Journal:  J Gastrointestin Liver Dis       Date:  2015-12       Impact factor: 2.008

4.  Activation of G-protein coupled estrogen receptor 1 improves early-onset cognitive impairment via PI3K/Akt pathway in rats with traumatic brain injury.

Authors:  Ze-Fen Wang; Zhi-Yong Pan; Cheng-Shi Xu; Zhi-Qiang Li
Journal:  Biochem Biophys Res Commun       Date:  2016-11-28       Impact factor: 3.575

5.  MicroRNA-375 is downregulated in pancreatic cancer and inhibits cell proliferation in vitro.

Authors:  Jian Zhou; Shiduo Song; Jiannong Cen; Dongming Zhu; Dechun Li; Zixiang Zhang
Journal:  Oncol Res       Date:  2012       Impact factor: 5.574

Review 6.  Diagnostic, functional, and therapeutic roles of microRNA in allergic diseases.

Authors:  Thomas X Lu; Marc E Rothenberg
Journal:  J Allergy Clin Immunol       Date:  2013-06-02       Impact factor: 10.793

Review 7.  Genetic resources for advanced biofuel production described with the Gene Ontology.

Authors:  Trudy Torto-Alalibo; Endang Purwantini; Jane Lomax; João C Setubal; Biswarup Mukhopadhyay; Brett M Tyler
Journal:  Front Microbiol       Date:  2014-10-10       Impact factor: 5.640

8.  Human UTY(KDM6C) is a male-specific Nϵ-methyl lysyl demethylase.

Authors:  Louise J Walport; Richard J Hopkinson; Melanie Vollmar; Sarah K Madden; Carina Gileadi; Udo Oppermann; Christopher J Schofield; Catrine Johansson
Journal:  J Biol Chem       Date:  2014-05-05       Impact factor: 5.157

9.  Impact of JAK2V617F Mutation Burden on Disease Phenotype in Chinese Patients with JAK2V617F-positive Polycythemia Vera (PV) and Essential thrombocythemia (ET).

Authors:  Shixiang Zhao; Xiang Zhang; Yang Xu; Yufeng Feng; Wenhong Sheng; Jiannong Cen; Depei Wu; Yue Han
Journal:  Int J Med Sci       Date:  2016-01-25       Impact factor: 3.738

10.  Regulation of MMP13 by antitumor microRNA-375 markedly inhibits cancer cell migration and invasion in esophageal squamous cell carcinoma.

Authors:  Yusaku Osako; Naohiko Seki; Yoshiaki Kita; Keiichi Yonemori; Keiichi Koshizuka; Akira Kurozumi; Itaru Omoto; Ken Sasaki; Yasuto Uchikado; Hiroshi Kurahara; Kosei Maemura; Shoji Natsugoe
Journal:  Int J Oncol       Date:  2016-10-21       Impact factor: 5.650

View more
  5 in total

1.  Intermittent Hypoxia Increased the Expression of DBH and PNMT in Neuroblastoma Cells via MicroRNA-375-Mediated Mechanism.

Authors:  Shin Takasawa; Ryogo Shobatake; Yoshinori Takeda; Tomoko Uchiyama; Akiyo Yamauchi; Mai Makino; Sumiyo Sakuramoto-Tsuchida; Keito Asai; Hiroyo Ota; Asako Itaya-Hironaka
Journal:  Int J Mol Sci       Date:  2022-05-24       Impact factor: 6.208

2.  Predictive role of plasmatic biomarkers in advanced non-small cell lung cancer treated by nivolumab.

Authors:  Adrien Costantini; Catherine Julie; Coraline Dumenil; Zofia Hélias-Rodzewicz; Julie Tisserand; Jennifer Dumoulin; Violaine Giraud; Sylvie Labrune; Thierry Chinet; Jean-François Emile; Etienne Giroux Leprieur
Journal:  Oncoimmunology       Date:  2018-04-20       Impact factor: 8.110

Review 3.  Milk Exosomal microRNAs: Postnatal Promoters of β Cell Proliferation but Potential Inducers of β Cell De-Differentiation in Adult Life.

Authors:  Bodo C Melnik; Gerd Schmitz
Journal:  Int J Mol Sci       Date:  2022-09-29       Impact factor: 6.208

Review 4.  Current Evidence on Potential Uses of MicroRNA Biomarkers for Migraine: From Diagnosis to Treatment.

Authors:  Parisa Gazerani
Journal:  Mol Diagn Ther       Date:  2019-12       Impact factor: 4.074

Review 5.  On the PHLPPside: Emerging roles of PHLPP phosphatases in the heart.

Authors:  Kellie A Lemoine; Julianna M Fassas; Shirag H Ohannesian; Nicole H Purcell
Journal:  Cell Signal       Date:  2021-07-25       Impact factor: 4.850

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.